APA (7th ed.) Citation

Leslie, J., Mackey, J. B. G., Jamieson, T., Ramon-Gil, E., Drake, T. M., Fercoq, F., . . . Mann, D. A. (2022). CXCR2 inhibition enables NASH-HCC immunotherapy. Gut, 71(10), . https://doi.org/10.1136/gutjnl-2021-326259

Chicago Style (17th ed.) Citation

Leslie, Jack, et al. "CXCR2 Inhibition Enables NASH-HCC Immunotherapy." Gut 71, no. 10 (2022). https://doi.org/10.1136/gutjnl-2021-326259.

MLA (9th ed.) Citation

Leslie, Jack, et al. "CXCR2 Inhibition Enables NASH-HCC Immunotherapy." Gut, vol. 71, no. 10, 2022, https://doi.org/10.1136/gutjnl-2021-326259.